Announced
Completed
Synopsis
Hellman & Friedman-backed Cordis, a firm engaged in the development and manufacturing of interventional cardiovascular and endovascular technologies, completed the acquisition of MedAlliance, a Swiss-based medical technology company, for $1.14bn. "The Cordis acquisition will accelerate access to this breakthrough technology for patients around the globe suffering from coronary and peripheral disease. I want to thank our entire MedAlliance team - including physicians, distributors and clinical patients - who have succeeded in disrupting the coronary and peripheral markets to provide a safe and effective new technology. The arsenal of SELUTION SLR DEB clinical data is designed to change medical practice and improve patient outcomes," Jeffrey B. Jump, MedAlliance Founder, Chairman and CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.